PharmEasy to formally discuss IPO plans with its board in second try
Budget with ET
India looks to bring more women into workforce
A game changing budget to revive India’s backbone — agriculture
How would you plan India's Budget? Give it a try
The company plans to discuss its IPO strategy with its board next month, including the possibility of a reverse merger with its listed subsidiary Thyrocare, they said.
The company aims to leverage its improved cash flow position and restructured business model to win the confidence of public market investors.
“They (PharmEasy) will discuss the IPO plan in the next board meeting in February. There should be more clarity on the route for the public offering, size and valuation after that,” a person aware of the plan said. “The significant reduction in cash burn has been a core focus for the firm during last year and it’s showing on the books now.”
PharmEasy did not comment on IPO plans.
Artificial Intelligence(AI)
Java Programming with ChatGPT: Learn using Generative AI
By — Metla Sudha Sekhar, IT Specialist and Developer
Artificial Intelligence(AI)
Basics of Generative AI: Unveiling Tomorrows Innovations
By — Metla Sudha Sekhar, IT Specialist and Developer
Artificial Intelligence(AI)
Generative AI for Dynamic Java Web Applications with ChatGPT
By — Metla Sudha Sekhar, IT Specialist and Developer
Artificial Intelligence(AI)
Mastering C++ Fundamentals with Generative AI: A Hands-On
By — Metla Sudha Sekhar, IT Specialist and Developer
Artificial Intelligence(AI)
Master in Python Language Quickly Using the ChatGPT Open AI
By — Metla Sudha Sekhar, IT
